Abstract

BackgroundMyofibrillar myopathies (MFM) are a subgroup of protein aggregate myopathies (PAM) characterized by a common histological picture of myofibrillar dissolution, Z-disk disintegration, and accumulation of degradation products into inclusions. Mutations in genes encoding components of the Z-disk or Z-disk-associated proteins occur in some patients whereas in most of the cases, the causative gene defect is still unknown. We aimed to search for pathogenic mutations in genes not previously associated with MFM phenotype.MethodsWe performed whole-exome sequencing in four patients from three unrelated families who were diagnosed with PAM without aberrations in causative genes for MFM.ResultsIn the first patient and her affected daughter, we identified a heterozygous p.(Arg89Cys) missense mutation in LMNA gene which has not been linked with PAM pathology before. In the second patient, a heterozygous p.(Asn4807Phe) mutation in RYR1 not previously described in PAM represents a novel, candidate gene with a possible causative role in the disease. Finally, in the third patient and his symptomatic daughter, we found a previously reported heterozygous p.(Cys30071Arg) mutation in TTN gene that was clinically associated with cardiac involvement.ConclusionsOur study identifies a new genetic background in PAM pathology and expands the clinical phenotype of known pathogenic mutations.

Highlights

  • Myofibrillar myopathies (MFM) are a group of protein aggregate myopathies (PAM) sharing the histological features of Z-disk dissolution, myofibrillar degeneration, and accumulation of degradation products into protein aggregates [1,2,3,4]

  • We studied three unrelated families in which the probands diagnosed with PAM had negative results by gene testing for MFM including DES, CRYAB, MYOT, LBD3/ZASP, Bcl2-associated athanogene-3 (BAG3), and filamin C (FLNC) (Fig. 1)

  • At the time of clinical evaluation, she was able to walk for short distances and had moderate to marked weakness of proximal four-limb muscles with a mild involvement of distal muscles of the upper limbs

Read more

Summary

Introduction

Myofibrillar myopathies (MFM) are a group of protein aggregate myopathies (PAM) sharing the histological features of Z-disk dissolution, myofibrillar degeneration, and accumulation of degradation products into protein aggregates [1,2,3,4]. Causative mutations have been identified in a minority of patients in one of the following genes: desmin (DES), αBcrystallin (CRYAB), myotilin (MYOT), Z-band alternatively spliced PDZ-containing protein (LBD3/ZASP), Bcl2-associated athanogene-3 (BAG3), and filamin C (FLNC) [1,2,3,4,5]. Myofibrillar myopathies (MFM) are a subgroup of protein aggregate myopathies (PAM) characterized by a common histological picture of myofibrillar dissolution, Z-disk disintegration, and accumulation of degradation products into inclusions. We aimed to search for pathogenic mutations in genes not previously associated with MFM phenotype.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call